🇺🇸 FDA
Patent

US 6423311

Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment

expired A61KA61K35/28A61K38/18

Quick answer

US patent 6423311 (Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jul 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Jul 23 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K35/28, A61K38/18, A61K38/193, A61P